Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86399 | Target Info | |||
Target Name | Bromodomain-containing protein 2 (BRD2) | ||||
Synonyms | Really interesting new gene 3 protein; RING3; O27.1.1; KIAA9001 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BRD2 | ||||
Biochemical Class | Bromodomain | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 1-[(2S,4R)-4-[(2-chlorophenyl)amino]-2-methyl-6-(1H-pyrazol-3-yl)-3,4-dihydroquinolin-1(2H)-yl]ethan-1-one | Ligand Info | |||
Canonical SMILES | CC1CC(C2=C(N1C(=O)C)C=CC(=C2)C3=CC=NN3)NC4=CC=CC=C4Cl | ||||
InChI | 1S/C21H21ClN4O/c1-13-11-20(24-19-6-4-3-5-17(19)22)16-12-15(18-9-10-23-25-18)7-8-21(16)26(13)14(2)27/h3-10,12-13,20,24H,11H2,1-2H3,(H,23,25)/t13-,20+/m0/s1 | ||||
InChIKey | XRGFSBWBLFRFEN-RNODOKPDSA-N | ||||
PubChem Compound ID | 135125430 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6DB0 N-Terminal bromodomain of Human BRD2 with a Tetrahydroquinoline analogue | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [1] |
PDB Sequence |
VTNQLQYLHK
84 VVMKALWKHQ94 FAWPFRQPVD104 AVKLGLPDYH114 KIIKQPMDMG124 TIKRRLENNY 134 YWAASECMQD144 FNTMFTNCYI154 YNKPTDDIVL164 MAQTLEKIFL174 QKVASMPQE |
|||||
|
||||||
PDB ID: 6DBC Second bromodomain of Human BRD2 with a Tetrahydroquinoline analogue | ||||||
Method | X-ray diffraction | Resolution | 1.05 Å | Mutation | No | [2] |
PDB Sequence |
GSHMQDPEQL
350 KHCNGILKEL360 LSKKHAAYAW370 PFYKPVDASA380 LGLHDYHDII390 KHPMDLSTVK 400 RKMENRDYRD410 AQEFAADVRL420 MFSNCYKYNP430 PDHDVVAMAR440 KLQDVFEFRY 450 AKMPD
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | N-Terminal bromodomain of Human BRD2 with a Tetrahydroquinoline analogue | ||||
REF 2 | Second bromodomain of Human BRD2 with a Tetrahydroquinoline analogue |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.